What Spark Therapeutics, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Mehra Anand | Director | Dec 17 | Tender Offer · U | −481,270 | $114.50 | −$55.1M | 0 |
| Mehra Anand | Director | Dec 17 | Tender Offer · U | −40,203 | $114.50 | −$4.6M | 0 |
| Ekman Lars | Director | Dec 17 | Tender Offer · U | −3,000 | $114.50 | −$344K | 0 |
| Zoth Lota S | CHIEF SCIENTIFIC OFFICER | Dec 17 | Tender Offer · U | −3,000 | $114.50 | −$344K | 0 |
| Milano Vincent | Director | Dec 17 | Tender Offer · U | −3,000 | $114.50 | −$344K | 0 |
| Perez Robert J | Director | Dec 17 | Tender Offer · U | −2,500 | $114.50 | −$286K | 0 |
| Webster Stephen W | CHIEF FINANCIAL OFFICER | Dec 17 | Tender Offer · U | −6,102 | $114.50 | −$699K | 0 |
| Altschuler Steven | Director | Dec 17 | Tender Offer · U | −28,000 | $114.50 | −$3.21M | 0 |
| Marrazzo Jeffrey D | CHIEF EXECUTIVE OFFICER | Dec 17 | Tender Offer · U | −355,215 | $114.50 | −$40.7M | 0 |
| High Katherine A | See Remarks | Dec 17 | Tender Offer · U | −278,834 | $114.50 | −$31.9M | 0 |
| Faga Daniel | Chief Business Officer | Dec 17 | Tender Offer · U | −38,828 | $114.50 | −$4.45M | 0 |
| Mingozzi Federico | CHIEF SCIENTIFIC OFFICER | Dec 17 | Tender Offer · U | −12,615 | $114.50 | −$1.44M | 0 |
| Sigal Elliot | Director | Dec 17 | Tender Offer · U | −14,214 | $114.50 | −$1.63M | 0 |
| La Barge Joseph | CHIEF LEGAL OFFICER | Dec 17 | Tender Offer · U | −200 | $114.50 | −$22.9K | 0 |
| La Barge Joseph | CHIEF LEGAL OFFICER | Dec 17 | Tender Offer · U | −50,193 | $114.50 | −$5.75M | 0 |
| Dalton Lisa | CHIEF HUMAN RESOURCE OFFICER | Dec 17 | Tender Offer · U | −4,134 | $114.50 | −$473K | 0 |
| Mingozzi Federico | Chief Scientific Officer | Jun 26 | Withheld — tax / exercise cost · F | −2,775 | $102.31 | −$284K | 12,615 |
| Mingozzi Federico | Chief Scientific Officer | Jun 26 | Exercise / conversion · M | +8,375 | — | — | 15,390 |
| Mehra Anand | Director | May 30 | Exercise / conversion · M | +1,500 | — | — | 40,203 |
| Ekman Lars | Director | May 30 | Exercise / conversion · M | +1,500 | — | — | 3,000 |
Loading...
